Inhibition of GGTase‐I and FTase disrupts cytoskeletal organization of human PC‐3 prostate cancer cells
- 1 August 2010
- journal article
- Published by Wiley in Cell Biology International
- Vol. 34 (8) , 815-826
Abstract
The mevalonate synthesis pathway produces intermediates for isoprenylation of small GTPases, which are involved in the regulation of actin cytoskeleton and cell motility. Here, we investigated the role of the prenylation transferases in the regulation of the cytoskeletal organization and motility of PC‐3 prostate cancer cells. This was done by using FTI‐277, GGTI‐298 or NE‐10790, the specific inhibitors of FTase (farnesyltransferase), GGTase (geranylgeranyltransferase)‐I and ‐II, respectively. Treatment of PC‐3 cells with GGTI‐298 and FTI‐277 inhibited migration and invasion in a time‐ and dose‐dependent manner. This was associated with disruption of F‐actin organization and decreased recovery of GFP–actin. Immunoblot analysis of various cytoskeleton‐associated proteins showed that the most striking change in GGTI‐298‐ and FTI‐277‐treated cells was a markedly decreased level of total and phosphorylated cofilin, whereas the level of cofilin mRNA was not decreased. The treatment of PC‐3 cells with GGTI‐298 also affected the dynamics of GFP–paxillin and decreased the levels of total and phosphorylated paxillin. The levels of phosphorylated FAK (focal adhesion kinase) and PAK (p‐21‐associated kinase)‐2 were also lowered by GGTI‐298, but levels of paxillin or FAK mRNAs were not affected. In addition, GGTI‐298 had a minor effect on the activity of MMP‐9. RNAi knockdown of GGTase‐Iβ inhibited invasion, disrupted F‐actin organization and decreased the level of cofilin in PC‐3 cells. NE‐10790 did not have any effect on PC‐3 prostate cancer cell motility or on the organization of the cytoskeleton. In conclusion, our results demonstrate the involvement of GGTase‐I‐ and FTase‐catalysed prenylation reactions in the regulation of cytoskeletal integrity and motility of prostate cancer cells and suggest them as interesting drug targets for development of inhibitors of prostate cancer metastasis.Keywords
This publication has 78 references indexed in Scilit:
- Geranylgeranyl transferase type II inhibition prevents myeloma bone diseaseBiochemical and Biophysical Research Communications, 2008
- Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesisClinical & Experimental Metastasis, 2008
- The cofilin pathway in breast cancer invasion and metastasisNature Reviews Cancer, 2007
- GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS–induced lung cancerJournal of Clinical Investigation, 2007
- Roles of microfilaments and microtubules in paxillin dynamicsBiochemical and Biophysical Research Communications, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Farnesyl Pyrophosphate Synthase Is the Molecular Target of Nitrogen-Containing BisphosphonatesBiochemical and Biophysical Research Communications, 1999
- Co-ordinated changes in expression of cell adhesion molecules in prostate cancerEuropean Journal of Cancer, 1997
- Regulation of intracellular actin polymerization by prenylated cellular proteinsJournal of Cell Biology, 1992
- Regulation of the mevalonate pathwayNature, 1990